×

Salix-Cosmo deal worth watching

9:15 AM ET Wed, 9 July 2014

Salix Pharmaceuticals has agreed to merge with Cosmo Pharmaceuticals. CNBC's David Faber and Jim Cramer discuss the growing trend of U.S companies shifting their tax domiciles abroad and why the Salix deal is worth keeping an eye on.